Trastuzumab without an anthracycline: better for early breast cancer

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1574, 2007-01, pp. : 13-14

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

In defence of trastuzumab for early breast cancer

By  

Inpharma, Vol. 1, Iss. 1521, 2006-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Trastuzumab: a guide to its use in early breast cancer

By Adis International Limited  

Drugs & Therapy Perspectives, Vol. 24, Iss. 12, 2008-12 ,pp. : 4-7

Adis International

Access to resources Recommend Favorite

Trastuzumab improves survival in early breast cancer

By  

Inpharma, Vol. 1, Iss. 1490, 2005-01 ,pp. : 13-14

Adis International

Access to resources Recommend Favorite

Economic Evaluation and Decision Making: Reimbursing Trastuzumab in Early-Stage Breast Cancer

By Simoens Steven  

PharmacoEconomics, Vol. 25, Iss. 3, 2007-01 ,pp. : 181-185

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of Trastuzumab in the Adjuvant Treatment of Early Breast Cancer: A Lifetime Model

By Millar J. Alasdair   Millward Michael J.  

PharmacoEconomics, Vol. 25, Iss. 5, 2007-01 ,pp. : 429-442

Adis International

Access to resources Recommend Favorite